Kentaro Sahashi Selected Research

Kentaro Sahashi Research Topics

8	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 08/2010
5	X-Linked Bulbo-Spinal Atrophy 07/2022 - 11/2015
3	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 01/2018 - 08/2010
2	Muscle Weakness 07/2022 - 11/2015
2	Atrophy 07/2022 - 11/2015
2	Alzheimer Disease (Alzheimer's Disease) 05/2022 - 08/2021
2	Nervous System Diseases (Neurological Disorders) 01/2022 - 08/2018
2	Neuromuscular Diseases (Neuromuscular Disease) 01/2019 - 01/2019
1	Nervous System Heredodegenerative Disorders 07/2022
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 05/2022
1	Tauopathies 05/2022
1	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2022
1	Muscular Diseases (Myopathy) 01/2022
1	Amyloidosis 08/2021
1	Proteostasis Deficiencies 08/2021
1	Familial Dysautonomia (Riley Day Syndrome) 01/2018
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2016
1	Body Weight (Weight, Body) 11/2015

6	polyglutamineIBA 01/2022 - 11/2015
5	Androgen Receptors (Androgen Receptor)IBA 07/2022 - 11/2015
3	Proteins (Proteins, Gene)FDA Link 07/2022 - 08/2010
2	Amyloid (Amyloid Fibrils)IBA 05/2022 - 08/2021
2	Adenine FDA LinkGeneric 01/2022 - 06/2021
2	GuanineIBA 01/2022 - 06/2021
2	CytosineIBA 01/2022 - 06/2021
2	Antisense OligonucleotidesIBA 01/2018 - 11/2015
1	AndrogensIBA 07/2022
1	FilaminsIBA 05/2022
1	Microfilament Proteins (Actin Binding Proteins)IBA 05/2022
1	Nucleic AcidsIBA 01/2022
1	solanezumabIBA 08/2021
1	Monoclonal AntibodiesIBA 08/2021
1	gantenerumabIBA 08/2021
1	lecanemabIBA 08/2021
1	aducanumabIBA 08/2021
1	Biomarkers (Surrogate Marker)IBA 08/2018
1	nusinersenIBA 01/2018
1	RNA Precursors (Precursor, mRNA)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	6- chloro- 9- (4- methoxy- 3,5- dimethylpyridin- 2- ylmethyl)- 9H- purin- 2- ylamineIBA 01/2016
1	purineIBA 01/2016
1	Ataxin-1IBA 01/2016
1	Therapeutic UsesIBA 01/2016

6	Therapeutics 01/2022 - 12/2014